TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting May 3, 2023
Longwood Fund Closes $180 Million Fund to Create and Invest in Early-Stage Biotechnology Companies May 3, 2023
Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research April 20, 2023
Lassen Therapeutics Presents Data Demonstrating Anti-IL18 Binding Protein Antibody Efficacy and Enhancement of Anti-Tumor Immunity April 18, 2023
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder April 6, 2023
Axial Therapeutics Announces Key R&D Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics March 30, 2023
